Dorsey & Whitney Trust CO LLC Reduces Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Dorsey & Whitney Trust CO LLC reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,160 shares of the pharmacy operator’s stock after selling 1,437 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Walgreens Boots Alliance were worth $151,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in the company. Brooklyn Investment Group increased its holdings in Walgreens Boots Alliance by 21.1% in the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after acquiring an additional 830 shares during the last quarter. First Financial Corp IN increased its stake in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares in the last quarter. CWA Asset Management Group LLC raised its position in shares of Walgreens Boots Alliance by 9.2% in the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after purchasing an additional 1,084 shares during the period. Metis Global Partners LLC raised its position in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock valued at $222,000 after purchasing an additional 1,118 shares during the period. Finally, OLD Second National Bank of Aurora lifted its stake in shares of Walgreens Boots Alliance by 35.1% during the 3rd quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock valued at $41,000 after buying an additional 1,185 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and lowered their target price for the company from $11.00 to $9.00 in a report on Friday, February 28th. Royal Bank of Canada boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Evercore ISI upped their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Finally, Bank of America raised their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $11.21 on Wednesday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $22.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The firm has a market capitalization of $9.69 billion, a price-to-earnings ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.62. The company’s fifty day moving average price is $10.71 and its 200-day moving average price is $9.73.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter last year, the business posted $0.66 earnings per share. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.